Background. The objective of this study is to determine the incidence and severity of acute pancreatitis (AP) in patients with end-stage renal disease (ESRD) on dialysis and whether the dialysis modality [hemodialysis (HD) versus peritoneal dialysis (PD)] confers a higher risk for AP as well as complications or mortality related to AP. Methods. We analyzed national health insurance claims data of 67 078 ESRD patients initiating dialysis between 1999 and 2007 in Taiwan. All patients were followed up from the start of their dialysis to first AP diagnosis, death, end of dialysis or 31 December 2008. Cox proportional hazards models were used to identify risk factors. Results. The cumulative incidence rates of AP were 0.6, 1.7, 2.6, 3.4 and 4% at 1, 3, 5, 7 and 9 years, respectively. ESRD patients on HD and PD had an AP incidence of 5.11 and 5.86 per 1000 person-years, respectively. Independent risk factors for AP in this population were being elderly, being female, having biliary stones or liver disease, and being on PD. Severe AP occurred in 44.9% of the HD patients and in 36% of the PD patients. Patients with AP on HD had a higher incidence of upper gastrointestinal (UGI) bleeding than those on PD (P ¼ 0.002). In contrast, those with AP on PD had a higher incidence of need for total parenteral nutrition (TPN) support than those on HD (P ¼ 0.072). Overall in-hospital mortality was 8.1%. The risk factors for mortality after an AP attack were male gender, increased age, AP severity, and the presence of diabetes mellitus or liver disease. Conclusions. ESRD patients on PD were at higher risk for AP than those on HD. HD patients with AP attacks had a greater incidence of UGI bleeding and PD patients with AP attacks a more frequent need for TPN support.
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I N T R O D U C T I O N
The prevalence of chronic kidney disease is increasing [1] . Patients with end-stage renal disease (ESRD) are more likely to develop pancreatic diseases [2] . One such disease, acute pancreatitis (AP), can occur with a severe, complicated course-associated with a high mortality rate [3] and increased economic burden [4] .
ESRD patients on dialysis are at higher risk for AP [5, 6] . In those on hemodialysis (HD), the incidence of AP is 0.67-14.10 per 1000 person-years, and in those on peritoneal dialysis (PD), it is 2.66-43 per 1000 person-years [5, [7] [8] [9] [10] [11] . Patients on dialysis have been found to be at higher risk for AP than the general population, whose annual AP incidences range from 0.04 to 0.45 per 1000 person-years [11] [12] [13] [14] . It is known that about 20% of patients with AP in the general population have a severe course [15, 16] , but there are only limited studies of the severity of AP in ESRD patients on dialysis. While Lankisch et al. [11] reported that 16% of the AP cases in patients with ESRD had severe courses, their results might have been underestimated by possible recall bias. No study has investigated the prognosis of severe AP in this patient population.
The incidence and prevalence rates of ESRD are high in Taiwan [17] , an administrative area whose residents are covered under the universal health insurance. We tapped the Taiwan National Health Insurance Research Database (NHIRD) to investigate the possible association between dialysis modality and AP incidence, severity and mortality in ESRD dialysis patients. and is released for research by the Taiwan National Health Research Institute. The NHIRD, which contains nearly all (99%) of the inpatient and outpatient claims for Taiwan's 23 million residents, is one of the largest and most comprehensive databases in the world, and it has been used extensively in various studies [18] [19] [20] [21] [22] . Patient identification numbers, gender, date of birth, dates of admission and discharge, medical institutions providing the services, the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic and procedure codes (up to five each) and outcomes are all encrypted. One of our variables, urbanization level, was based on a study by the National Health Research Institutes and modified from seven levels into the following three categories for our study: urban level (levels 1 and 2), suburban level (levels 3 and 4) and rural level (levels 5-7) [23] . We used the NHIRD for ambulatory care claims, all inpatient claims and the updated registry for beneficiaries from 1998 to 2008 for this study. All datasets can be interlinked using a beneficiary's unique personal identification number.
Patient selection and definition
This longitudinal cohort study selected ESRD patients on maintenance dialysis who began renal replacement therapy between 1 January 1999 and 31 December 2007 (n ¼ 68 300). ESRD patients on maintenance dialysis were defined as having undergone dialysis for more than 90 days. Patients who had undergone renal transplantation before beginning dialysis (n ¼ 357) or were aged <18 years old (n ¼ 304) were excluded. All patients were followed up from their first reported date of dialysis to their date of first AP diagnosis, end of dialysis, death or 31 December 2008.
The inpatient claims include the records of all hospitalizations and provide a substantial amount of information. We linked study subjects to the inpatient claims data to identify the first episode of AP (ICD-9-CM: 577.0) after initiation of dialysis. Patients with a diagnosis of chronic pancreatitis (ICD-9-CM: 577.1) (n ¼ 561) were excluded. The remaining 67 078 incident dialysis patients were analyzed in this study. A total of 1383 of these patients were diagnosed with AP during the follow-up period.
Demographic and comorbid variables
We linked to the diagnostic codes used on both NHI inpatient and outpatient claims databases. We collected survival status, date of death, patient demographics and baseline comorbidities. Baseline comorbidities-including biliary stone, alcohol abuse, diabetes mellitus (DM), hypertriglyceridemia, liver disease-are important factors affecting the episode of AP [4] .
Definition of severe acute pancreatitis
Severe AP was defined mainly according to the Atlanta classification [24] , but modified by intensive care unit (ICU) admission, acute organ dysfunction, upper gastrointestinal (UGI) bleeding, or the requirement of drainage for pancreatic abscess or cysts [4] .
Statistical analyses
The incidence of newly diagnosed AP was expressed as the number of cases of AP per 1000 person-years. Parametric Pearson's chi-square test was used to compare each variable in patients with and without AP. Age was entered as a categorical variable (18-44, 45-64 and ! 65 years). Significance was set at P < 0.05. Kaplan-Meier was used to calculate cumulative proportion of patients with AP as well as cumulative proportion of survivors after AP attack. Cox proportional hazards models were used to identify the risk factors of AP and mortality after AP. Hazard ratios (HRs) and 95% confidence intervals (CIs) were derived from Cox proportional hazards models. Cox models met the assumption of proportionality of risks. Multivariate analyses were used to model all-cause mortality, adjusting for potential confounders in the relationship between comorbidities and the risk of mortality. All statistical operations were performed using the Statistical Package for Social Sciences for Windows 17.0 (SPSS Inc., Chicago, IL, USA).
R E S U L T S Demographics and clinical characteristics
A total 67 078 adult incident dialysis patients were enrolled in this study. During the follow-up period, 1383 (2.06%) of these patients were diagnosed with AP (1.7% of males and 2.4% of females; P < 0.001) ( Table 1 ). The crude incidence of AP was 5.17 (95% CI 4.90-5.44) per 1000 person-years. There were no significant differences among the different age groups with regard to incidence of AP (P ¼ 0.555). Patients who lived in urban areas had a lower incidence of AP than those in suburban or rural areas (P ¼ 0.01). Patients on PD tended to have a higher incidence of this disease than those on HD (P ¼ 0.449). Patients on HD and those on PD had an AP incidence rate of 5.11 (95% CI 4.84-5.40) and 5.86 (95% CI 4.84-7.03) per 1000 personyears, respectively. Patients with AP tended to have more comorbidities than those without AP. Many more patients with AP had biliary stones, hypertriglycemia and liver disease than those without AP.
Cumulative incidence and risk factors for acute pancreatitis
Being female, being elderly, receiving PD and having biliary stones or liver disease were risk factors for AP in dialysis
patients by multivariate analysis (Table 2) . Patients !65 years old were 41% more likely to be diagnosed with AP than those 18-44 years old (HR 1.41, 95% CI: 1.19-1.67). Urbanization was associated with a lower risk for AP. Patients living in rural areas were 31% more likely to have an AP attack than those residing in urban areas (HR 1.31, 95% CI: 1.13-1.51) . Patients on PD had a 1.28-fold increased risk of AP compared with those on HD (HR 1.28, 95% CI: 1.05-1.56). The baseline comorbidities independently associated with increased risk of AP were biliary stone (HR 1.45, 95% CI: 1.07-1.97) and liver disease (HR 1.32, 95% CI: 1.11-1.56).
The cumulative incidence rates of AP were 0.6% at 1 year, 1.7% at 3 years, 2.6% at 5 years, 3.4% at 7 years and 4% at 9 years ( Figure 1 ). Only a minority of dialysis patients with AP had known causes, as <20% of HD patients and <10% of PD patients with this disease had identifiable risk factors (Table 3) .
As can been seen in Table 3 , which analyzes severe AP by dialysis modalities, we found severe AP in 44.9% of those on HD and 36% of those on PD (P ¼ 0.072). Of the patients on HD and of those on PD who had AP attacks, 19.3 and 16.2%, respectively, were admitted to ICUs (P ¼ 0.433). Patients with AP on HD had a higher incidence of UGI bleeding than those on PD (P ¼ 0.002). In contrast, patients with AP on PD had a higher incidence of needing total parenteral nutrition (TPN) support than those on HD (P ¼ 0.003).
Cumulative survival rate and risk factors for all-cause mortality after acute pancreatitis Overall in-hospital mortality was 8.1% (Figure 2) . The cumulative survival rates after AP were 80.3% at 6 months, 75.3% at 1 year and only 42.8% at 5 years. We further analyzed the data in ESRD patients without AP and found the 0.5-, 1-and 5-year cumulative survival rates to be 95, 90 and 61% in those on HD and 97, 93 and 70% in those on PD, respectively. Multivariate Cox hazards analysis revealed mortality after an AP attack to be significantly associated with male gender (HR 1.24, 95% CI: 1.06-1.46), being !65 years of age (HR 2.87, 95% CI: 2.09-3.93), increased severity (HR 1.53, 95% CI: 1.31-1.80), DM (HR 1.18,95% CI: 1.00-1.38) and liver disease (HR 1.32, 95% CI: 1.05-1.66), but not with dialysis modality (Table 4) .
D I S C U S S I O N
This investigation represents the first national longitudinal cohort study to evaluate AP incidence, severity and mortality in patients with ESRD on dialysis. We found an association between PD modality and increased risk of AP in patients with ESRD (Table 2) ; there was an association between HD modality and increased severity of AP when the disease occurred in these patients (Table 3) . However, ESRD patients on HD had a higher incidence of UGI bleeding, and those on PD had a higher incidence of need for TPN support (Table 3) . Overall in-hospital mortality was 8.1% (Figure 1 ). Mortality after an AP attack was associated with male gender, increased age, severity of pancreatitis, and the presence of DM or liver disease (Table 4) .
The incidence of AP has been reported to be higher among ESRD patients on dialysis than that in the general population [5] ; in addition, it has been found to be higher in patients on PD than in those on HD [2] . Shen and Lu [4] reported the incidence of AP to be 0.428 per 1000 person-years in the general population in Taiwan. Our study found the incidence of AP to be 5.17 per 1000 person-years in ESRD dialysis patients, an incidence consistent with those reported in Western countries [9, 10] . A nationwide study in Germany has reported the incidence of AP in dialysis patients to be much lower (0.67 and 2.66 per 1000 person-years for those on HD and PD, respectively) [11] . The lower incidence reported in that study may have been due to recall bias as the study was conducted 
using questionnaire [11] . The common causes of AP in the general population are alcohol abuse and biliary stone, but there were a few patients in our study whose causes were identified (<20% of HD patients, and <10% of PD patients). In the general population, only 10-40% will have unidentified causes [24, 25] . The rate of idiopathic AP is higher in dialysis patients [11, 26] . Our study identified the factors putting dialysis patients at risk of AP to be old age, female gender, biliary stones, liver disease and PD. We found the incidence of AP was higher in patients on PD (5.86 per 1000 person-years) than those on HD (5.11 per 1000 person-years), and the result was consistent with previous studies [5, [7] [8] [9] [10] [11] . Lankisch et al. [11] reported the incidence of severe pancreatitis to be 10.8% in HD patients and 44.4% in PD patients in Germany, though interpretation of the results of their questionnaire-based study may be limited by possible recall bias, and also in their study the number of patients with AP was small. Our large nationwide study found that 44.9% of those on HD and 36% of those on PD had severe AP. A study from the Henry Ford Health System, which is a vertically integrated health-care delivery system in the metropolitan Detroit area, reported both groups to have higher rates of ICU admission (29% in HD and 33% in PD), though the percentage was just based on four patients on HD and two on PD [10] . Our study found no significant association between ICU admission and dialysis modality (P ¼ 0.433). However, we did find a higher incidence of UGI bleeding in the HD group and higher incidence of need for TPN support in the PD group. There are no previous studies with which these findings can be compared.
Our study has several limitations. One limitation is that our identification of comorbidities was based on insurance claims using ICD-9-CM diagnosis codes. There is some possibility of misclassification. Another limitation is that our study lacked specific data on dialysis adequacy, patient compliance, nutritional status, biochemical data and socioeconomic characteristics. Still another limitation is that our findings may not necessarily be relevant to countries outside Taiwan, where incidence of ESRD is among the world's highest and herbal nephropathy is common.
In conclusion, ESRD patients on PD had a higher risk of an attack of AP than those on HD. Those on HD with AP attacks had a higher incidence of UGI bleeding and those on PD with AP attacks had a higher incidence of need for TPN support. The risk factors for mortality after AP in ESRD patients were male gender, old age, AP severity, DM and liver disease.
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